Lsv Asset Management Ptc Therapeutics, Inc. Transaction History
Lsv Asset Management
- $45.3 Billion
- Q3 2025
A detailed history of Lsv Asset Management transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 2,700 shares of PTCT stock, worth $182,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,700Holding current value
$182,844% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
314Shares Held
79.7MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$599 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$526 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$525 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$321 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$318 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.84B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...